top
Search terms
Results 61 - 70 of 92 - ordered by :
Pages: 1 ... 4 5 6 7 8 9 10
Escardio

In 2016 the CROS study has shown that even in the era of statin use and acute revascularisation, multidisciplinary cardiovascular (CV) rehabilitation leads to significant reductions in morbidity and ...

Date : 18/01/2019
Escardio

The findings, presented today at the ESC and published simultaneously in the New England Journal of Medicine, provide information that will help guide clinical practice and resolve uncertainty over ...

Date : 01/09/2013
Escardio

Monitoring platelet function in order to individualize antiplatelet therapy did not improve outcomes for elderly patients after a heart attack compared to a standard, unmonitored approach, results of ...

Date : 28/08/2016
Escardio

EMBARGO : 29 August 2015 at 13:00 BST The study in more than 35 000 patients found that the risk of further stroke or heart attack, heart failure or dying due to heart disease at four years was 83% ...

Date : 29/08/2015
Escardio

Prof. Zannad points out that, “Rivaroxaban is approved at higher doses to treat conditions such as atrial fibrillation (AF) and venous thromboembolism, but in COMMANDER HF, patients were ...

Date : 28/08/2018
Escardio

The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology. Professor Bertram Pitt said: “We’ve had many studies showing that ACE ...

Date : 18/05/2014
Escardio

Heart failure patients treated with the heart rate slowing agent ivabradine have a significantly reduced risk of being readmitted to hospital during the high-risk ‘vulnerable period’ just ...

Date : 21/05/2016
Escardio

Increased levels of copeptin were associated with increased frequencies of typical co-morbidities of heart failure, increased severity of heart failure, and increased risk of all-cause death. ...

Date : 25/08/2012
Escardio

Hot Line III - Diabetes Mellitus/Pharmacology In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of ...

Date : 31/08/2015
Escardio

Sleeping pills increase the risk of cardiovascular events in heart failure patients by 8-fold, according to research from Japan. The researchers retrospectively examined the medical records of 111 ...

Date : 17/05/2014